0000899243-21-017261.txt : 20210428
0000899243-21-017261.hdr.sgml : 20210428
20210428203009
ACCESSION NUMBER: 0000899243-21-017261
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210426
FILED AS OF DATE: 20210428
DATE AS OF CHANGE: 20210428
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Green John L.
CENTRAL INDEX KEY: 0001709773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38443
FILM NUMBER: 21866568
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cogent Biosciences, Inc.
CENTRAL INDEX KEY: 0001622229
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465308248
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-945-5576
MAIL ADDRESS:
STREET 1: 200 CAMBRIDGE PARK DRIVE
STREET 2: SUITE 3100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics Inc.
DATE OF NAME CHANGE: 20180402
FORMER COMPANY:
FORMER CONFORMED NAME: Unum Therapeutics, Inc.
DATE OF NAME CHANGE: 20141014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-04-26
0
0001622229
Cogent Biosciences, Inc.
COGT
0001709773
Green John L.
C/O COGENT BIOSCIENCES, INC.
200 CAMBRIDGE PARK DRIVE, SUITE 2500
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Common Stock
2021-04-26
4
S
0
17813
8.86
D
3841
D
The shares were sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units previously granted to the Reporting Person.
The price reported in Column 4 was the weighted-average sale price of the shares. The shares were sold in multiple transactions at prices ranging from $8.80 to $8.90. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range set forth herein.
/s/ Ryan Murr, Attorney-in-Fact
2021-04-28